
|Articles|September 24, 2015
Bristol-Myers Squibb to Take Part in Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
Bristol-Myers Squibb will take part in Leerink Partners Immuno-Oncology Roundtable on October 1.
Advertisement
PRESS RELEASE
NEW YORK--(
Investors and the general public are invited to listen to a live webcast of the session at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
4
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
5




























































































































